Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin Effect in Hemorrhagic Stroke Patients
IRCT201610225073N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in brain hemorrhage (ICH), sponsored by Tehran University of Medical Sciences. Started Nov 2016; status: completed.
02
Drugs
melatonin
03
Conditions
brain hemorrhage (ICH)
Beyond the preview
Go deeper on IRCT201610225073N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201610225073N2.